PACB

1.6207.95%
MV

Mark Van Oene

CEO, President, Director & Interim CFO

Mr. Mark Van Oene Ph.D., is an Interim Chief Financial Officer at Pacific Biosciences of California, Inc. since November 3, 2026. He had been Chief Operating Officer at Pacific Biosciences of California, Inc. since January 8, 2021 until August 05, 2026 and serves as its President, CEO & Director since August 05, 2026. Mr. Van Oene joined Pacific Biosciences of California from Illumina, Inc on January 8, 2021. He served as Senior Vice President and Chief Commercial Officer of Illumina, Inc. since May 22, 2017 till January 2021 and also served as its Senior Vice President since April 2016. In that role, he was responsible for the development and implementation of Illumina’s commercial strategy and oversaw worldwide sales and services. Mr. Van Oene served as an Interim Chief Commercial Officer of Illumina, Inc. from January 31, 2017 to May 22, 2017 and also served as General Manager of Americas Commercial Operations until May 22, 2017. He joined Illumina in 2006 as a regional account Manager in its sales organization and advanced rapidly taking on senior commercial leadership roles with ever increasing areas of responsibility. He served as Vice President, Global Sales at Illumina. During his tenure at Illumina. Mr. Van Oene was instrumental in scaling Illumina’s global commercial organization, representing the voice of their customers and driving significant revenue growth. Mr. Van Oene serves as a member of the board of directors of Dante Labs Inc. Mr. Van Oene holds B.S. in biochemistry from Western University. He has a Ph.D in Molecular and Medical Genetics from University of Toronto.

Positions